Clinical Trials in Philadelphia

Showing 7101-7120 of 20,904 trials

Assessment of Macrophage Activation syndromE in STill's Disease

NCT06405152

Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics

Macrophage Activation SyndromeStill's Disease, Adult-OnsetStills Disease, Juvenile-Onset

Swedish Orphan Biovitrum75 participantsStarted Sep 2023

Los Angeles, California, United States • Atlanta, Georgia, United States • Cincinnati, Ohio, United States +8 more locations

COMPLETEDNA< 1 mile

Sleep in Pediatric HSCT

NCT04106089

Through an aggregated N=1 randomized controlled design (each patient will serve as their own control, with the 5-day intervention period determined by randomization), the current study will test the acceptability, feasibility, and impact on sleep and supportive care engagement of protecting one 6-hour window for nighttime sleep (intervention) relative to regular vitals checks (observation only periods) during Hematopoietic Stem Cell Transplant (HSCT) recovery.

SleepStem Cell Transplant Complications

Children's Hospital of Philadelphia50 participantsStarted Nov 2019

Philadelphia, Pennsylvania, United States

WITHDRAWNPhase 1/2< 1 mile

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

NCT03973333

IMC-C103C is an immune mobilizing monoclonal T cell receptor against cancer (ImmTAC ®) designed for the treatment of cancers positive for the tumor-associated antigen MAGE-A4. This is a first-in-human trial designed to evaluate the safety and efficacy of IMC-C103C in adult patients who have the appropriate HLA-A2 tissue marker and whose cancer is positive for MAGE-A4.

Select Advanced Solid Tumors

Immunocore LtdStarted May 2019

Los Angeles, California, United States • Sacramento, California, United States • Aurora, Colorado, United States +16 more locations

Assessment of Macrophage Activation syndromE in STill's Disease

Sleep in Pediatric HSCT

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Find Trials by Condition in Philadelphia

Hypotension Prediction Index Study (HPI Study)

QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

PK and Dose Escalation and Expansion Study of DST-2970

Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women

Milademetan in Advanced/Metastatic Solid Tumors

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Vogelxo(R) ABPM Study in Hypogandal Men

Study to Compare the Use of a Behavioral Health App Versus Care As Usual for 16-22 Year Olds with Depression

Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)